Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy of study drug (BMS-820836) as compared
with continued duloxetine in the treatment of patients with treatment resistant depression
(TRD).